Health Policy & Reimbursement Executive Director

At Amgen, if you feel like you are a part of something bigger, it’s because you are. Our shared mission—to serve patients living with serious illnesses—drives all that we do. Since 1980, we’ve helped pioneer the world of biotech in our fight against the world’s toughest diseases. With our focus on four therapeutic areas –Oncology, Inflammation, General Medicine, and Rare Disease– we reach millions of patients each year.

As a member of the Amgen team, you’ll help make a lasting impact on the lives of patients as we research, manufacture, and deliver innovative medicines to help people live longer, fuller happier lives. Our award‑winning culture is collaborative, innovative, and science based. If you have a passion for challenges and the opportunities that lay within them, you’ll thrive as part of the Amgen team.

Join us and transform the lives of patients while transforming your career.

Let’s do this. Let’s change the world. In this vital role the Health Policy & Reimbursement Executive Director will lead development and implementation of reimbursement strategies for federal (US) payer issues across multiple therapeutic areas and the company’s biosimilar portfolio. He/she will work cross‑functionally to help identify and resolve barriers to entry for pipeline products/ therapies and provide broad reimbursement‑related advice for inline products, including mitigation strategies in response to proposals that would negatively affect access of Amgen therapies for patients.

In addition, he/she will manage broader health policy efforts including reviewing and analyzing complex policy proposals including regulatory proposals and legislative text, and promptly and concisely communicating impact of these proposals to key internal audiences (government affairs, commercial, regulatory, clinical, and senior executives). This position requires intense collaboration with government affairs staff to ensure alignment of strategy, talking points and messaging to constituents (elected officials/leaders, agencies, third parties, etc.).

Further, the successful candidate will play a key role in health policy engagement with major trade associations on corporate policy priorities which include Amgen specific priorities as well as industry‑wide priorities including, but not limited to, Federal drug pricing policy. In partnership with trades or independently, he/she may also conduct research and integrate clinical, market and payer data to inform engagement on reimbursement objectives.

The Health Policy Executive Director will regularly update via written and oral communications to senior executives and other key partners on various reimbursement and US health policy topics.

We are all different, yet we all use our unique contributions to serve patients. The professional we seek is a leader with these qualifications.

• Doctorate degree & 6 years of health policy or reimbursement experience OR

• Master’s degree & 10 years of health policy or reimbursement experience OR

• Bachelor’s degree & 12 years of health policy or reimbursement experience AND

• 6 years of managerial experience directly managing people and/or leadership experience leading teams, projects, programs, or directing the allocation of resources

• Experience with Congressional Budget Office style modelling, cost estimates, and analyses

• Experience/relationships with key agencies including HHS, CMS, and CBO

• Deep understanding of Federal (US) and/or commercial payer environment including areas of (1) healthcare product and service coverage, coding, and reimbursement, (2) health policy, and (3) Federal (US) Executive and Legislative Branch healthcare policy‑setting authorities, processes, and responsible parties

• Broad and deep experience in federal health policy issues – specifically Medicare, Medicaid, and national health programs/reform

• Deep understanding of US biosimilars marketplace and its history/evolution

• Experience reviewing clinical literature, including disease state information and target product profiles to understand implications of payer actions and develop submissions for Federal…